- Home
- RSLS vs CMND Comparison
RSLS vs CMND Comparison
Compare RSLS & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- CMND
- Stock Information
- Founded
- RSLS 2002
- CMND 2017
- Country
- RSLS United States
- CMND Canada
- Employees
- RSLS N/A
- CMND N/A
- Industry
- RSLS Medical/Dental Instruments
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- RSLS Health Care
- CMND Health Care
- Exchange
- RSLS Nasdaq
- CMND Nasdaq
- Market Cap
- RSLS 4.5M
- CMND 5.2M
- IPO Year
- RSLS 2007
- CMND N/A
- Fundamental
- Price
- RSLS $2.56
- CMND $0.89
- Analyst Decision
- RSLS Hold
- CMND
- Analyst Count
- RSLS 1
- CMND 0
- Target Price
- RSLS N/A
- CMND N/A
- AVG Volume (30 Days)
- RSLS 7.3M
- CMND 119.9K
- Earning Date
- RSLS 08-13-2025
- CMND 07-01-2025
- Dividend Yield
- RSLS N/A
- CMND N/A
- EPS Growth
- RSLS N/A
- CMND N/A
- EPS
- RSLS N/A
- CMND N/A
- Revenue
- RSLS $7,175,000.00
- CMND N/A
- Revenue This Year
- RSLS $52.80
- CMND N/A
- Revenue Next Year
- RSLS N/A
- CMND N/A
- P/E Ratio
- RSLS N/A
- CMND N/A
- Revenue Growth
- RSLS N/A
- CMND N/A
- 52 Week Low
- RSLS $2.23
- CMND $0.80
- 52 Week High
- RSLS $414.99
- CMND $2.30
- Technical
- Relative Strength Index (RSI)
- RSLS 36.91
- CMND 42.87
- Support Level
- RSLS $2.45
- CMND $0.80
- Resistance Level
- RSLS $2.87
- CMND $0.98
- Average True Range (ATR)
- RSLS 0.68
- CMND 0.06
- MACD
- RSLS 0.14
- CMND -0.00
- Stochastic Oscillator
- RSLS 5.45
- CMND 36.00
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.